We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Blood Gas and Electrolyte Analyzers Market to Surpass USD 2.1 Billion by 2025

By LabMedica International staff writers
Posted on 06 Nov 2019
The global blood gas and electrolyte analyzers market is projected to grow at a CAGR of 6.5% during the forecast period, 2018-2025 to reach a value of over USD 2.1 billion by 2025, driven mainly by the Bench Top segment which is anticipated to bring in healthy gains and add significant momentum to the market growth. More...
The Bench Top segment is projected to grow at a CAGR of over 6.4% during the forecast period.

Geographically, several macroeconomic factors and internal market forces will shape the growth and development of demand patterns in the emerging countries in Asia-Pacific, Latin America and the Middle East. In North America, the US blood gas and electrolyte analyzers market is expected to grow at a CAGR of 5.5% during the forecast period. Within Europe, Germany is projected to add sales of over USD 64.4 million to the region’s blood gas and electrolyte analyzers market over the next 5 to 6 years. Over USD 55.9 million worth of demand in the region is projected to come from the Rest of Europe markets. In Japan, the Bench Top segment is expected to reach a market size of USD 97.6 million by the end of the forecast period.

The blood gas and electrolyte analyzers market in China, which is the world's second largest-economy and the new game changer in the global markets, is projected to grow at the rate of 9.6% over the next couple of years and add approximately USD 498.3 million in terms of addressable opportunity.



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.